Trastuzumab for early breast cancer
Authors:
- 1 March 2006
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 367 (9512) , 728
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Randomized Trials Stopped Early for BenefitJAMA, 2005
- Herceptin and early breast cancer: a moment for cautionThe Lancet, 2005
- Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31Journal of Clinical Oncology, 2005
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005